Sanofi Ventures

Portfolio Companies 2026 for Sanofi Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Sanofi Ventures accounts for 48 tracked companies with verified cap-table data, 48 of which disclose round sizes totalling $7.8B. The median disclosed raise is $144M, and the largest is Mirador Therapeutics at $650M, ahead of AdvanCell ($440M) and Prometheus Biosciences ($400M).

The names that recur most often on these portfolio cap tables are Sanofi Ventures (48 companies), OrbiMed (9 companies), RA Capital Management (6 companies), Janus Henderson Investors (6 companies), EQT Life Sciences (5 companies), Atlas Venture (5 companies). By latest disclosed round, the market skews Series B (17), Series A (16), Series D (5), Series C (5).

Best funded Sanofi Ventures companies

  1. Mirador Therapeutics — $650M (latest: Series B)
  2. AdvanCell — $440M (latest: Series D)
  3. Prometheus Biosciences — $400M (latest: Series A)
  4. Ollin Biosciences — $330M (latest: Series B)
  5. Atalanta Therapeutics — $262M (latest: Series B)
  6. Diagonal Therapeutics — $253M (latest: Series B)
  7. Escient Pharmaceuticals — $238M (latest: Series C)
  8. Science 37 — $235M (latest: Series D)
  9. Click Therapeutics — $218M (latest: Series D)
  10. Nuvig Therapeutics — $208M (latest: Series B)
  11. Tessa Therapeutics — $200M (latest: Series A)
  12. Abcuro — $200M (latest: Series C)
  13. Windward Bio — $200M (latest: Series A)
  14. ROME Therapeutics — $199M (latest: Series B)
  15. Curevo — $192M (latest: Series B)

Sanofi Ventures — related firms and companies (51)

Sanofi Ventures profile · All research reports